The frontiers of microbial health still hold significant, unexplored territory, yet insights about bacteria and their health effects are forging their way into new treatments for gut issues. The randomized trial published last month in the American Journal of Gastroenterology showed the artificial intelligence (AI)-powered personalized diet compared favorably to the low-FODMAP diet for IBS management. The AI-generated diet also had the added benefit of creating more diversity in the gut microbiome—and diversity in bacteria has been associated with better health outcomes.
FODMAP is the acronym for fermentable oligosaccharides, disaccharides, monosaccharides, and polyols—small carbohydrates the body can’t digest without a robust microbial community. The diet was developed by Monash University, particularly for IBS and other digestive symptoms. “It is a very strict elimination diet that only suppresses symptoms and does not address the root cause of the problem.
Due to its nature, sustainable adherence to the diet is very hard and alerts risk for nutritional deficiencies,” said Yüsra Serdaroğlu, head of nutrition at Enbiosis Biotechnology, designers of the app, said in an email to The Epoch Times. “Professionals have already started to highlight even personalization of the low-FODMAP diet.” Eliminating all FODMAP foods for two to six weeks Introducing those foods back into the patient’s diet one at a time over eight to 12 weeks Adjusting the diet to include o.
